Reporting Uncertainty Around Health-State Values: A Standard Method and Worked Example

IF 4.9 2区 医学 Q1 ECONOMICS Value in Health Pub Date : 2025-02-01 DOI:10.1016/j.jval.2024.11.010
Nancy J. Devlin PhD , Giselle Abangma MSc , Andrew Lloyd DPhil , David Parkin DPhil , Andrew Briggs DPhil
{"title":"Reporting Uncertainty Around Health-State Values: A Standard Method and Worked Example","authors":"Nancy J. Devlin PhD ,&nbsp;Giselle Abangma MSc ,&nbsp;Andrew Lloyd DPhil ,&nbsp;David Parkin DPhil ,&nbsp;Andrew Briggs DPhil","doi":"10.1016/j.jval.2024.11.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>Articles reporting value sets typically only report the standard errors (SEs) around each estimated coefficient in value set models. This is important information but does not help those building cost-effectiveness models, who need to know the uncertainty around the values of health states to conduct sensitivity analyses. This report’s aim is to demonstrate how SEs around health-related quality of life values can be calculated, using the example of the UK EQ-5D-3L value set.</div></div><div><h3>Methods</h3><div>We show how information from a model’s variance/covariance matrix can be used to estimate SEs for every health-state value, whether it is part of the modeling data set or not. Data from the Measurement and Valuation of Health study were used to replicate the original UK value set and the variance/covariance matrix and to produce SEs around the values for all 243 EQ-5D-3L states.</div></div><div><h3>Results</h3><div>The range of the SEs is small compared with the range of the health-state values but is conditional on a correct model specification and may be sensitive to alternative specifications.</div></div><div><h3>Conclusions</h3><div>Reporting these SEs should become routine practice in reporting value sets, to ensure that users are provided with information on parameter uncertainty. These SEs only capture one specific aspect of the sources of uncertainty around health-related quality of life values but represent a first step toward a more complete account of uncertainty in the preference weights used to estimate quality-adjusted life-years.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"28 2","pages":"Pages 191-196"},"PeriodicalIF":4.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1098301524067871","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

Articles reporting value sets typically only report the standard errors (SEs) around each estimated coefficient in value set models. This is important information but does not help those building cost-effectiveness models, who need to know the uncertainty around the values of health states to conduct sensitivity analyses. This report’s aim is to demonstrate how SEs around health-related quality of life values can be calculated, using the example of the UK EQ-5D-3L value set.

Methods

We show how information from a model’s variance/covariance matrix can be used to estimate SEs for every health-state value, whether it is part of the modeling data set or not. Data from the Measurement and Valuation of Health study were used to replicate the original UK value set and the variance/covariance matrix and to produce SEs around the values for all 243 EQ-5D-3L states.

Results

The range of the SEs is small compared with the range of the health-state values but is conditional on a correct model specification and may be sensitive to alternative specifications.

Conclusions

Reporting these SEs should become routine practice in reporting value sets, to ensure that users are provided with information on parameter uncertainty. These SEs only capture one specific aspect of the sources of uncertainty around health-related quality of life values but represent a first step toward a more complete account of uncertainty in the preference weights used to estimate quality-adjusted life-years.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
报告健康状态值的不确定性:一种标准方法和工作示例。
目的:报告值集的论文通常只报告值集模型中每个估计系数周围的标准误差(SEs)。这是重要的信息,但对那些建立成本效益模型的人没有帮助,因为他们需要知道健康状态值的不确定性,以便进行敏感性分析。本文的目的是利用英国EQ-5D-3L值集的例子,演示如何计算HRQoL值周围的se。方法:我们展示了如何使用来自模型方差/协方差矩阵的信息来估计每个健康状态值的se,无论它是否是建模数据集的一部分。来自健康测量和评估研究的数据被用来复制原始的UK值集和方差/协方差矩阵,并在所有243个EQ-5D-3L状态的值周围产生标准误差。结果:与健康状态值的范围相比,se的范围较小,但以正确的模型规格为条件,并且可能对替代规格敏感。结论:报告这些se应成为报告值集的常规做法,以确保向用户提供参数不确定性信息。这些se仅捕获HRQoL值不确定性来源的一个特定方面,但是代表了对用于估计QALYs的偏好权重的不确定性进行更完整说明的第一步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Value in Health
Value in Health 医学-卫生保健
CiteScore
6.90
自引率
6.70%
发文量
3064
审稿时长
3-8 weeks
期刊介绍: Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.
期刊最新文献
Newer GLP-1 RAs Are Associated With Improved Glycemic Control in US Adults With Type 2 Diabetes: a Population-Level Time Series Analysis. Role of Health Equity in Health Technology Assessment Process in Asia: A Landscape Analysis of 13 Health Systems in Asia. Understanding the economic value of interventions that address perinatal mental health problems: Literature review and methodological considerations. Are Updated COVID-19 Vaccines Still Relevant for all Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia. Capturing the Additional Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists Beyond the Control of Traditional Risk Factors in People with Diabetes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1